# Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study

> **NCT01213810** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Zurich**

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** Zostavax

## Key facts

- **NCT ID:** NCT01213810
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-12
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01213810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01213810, "Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01213810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*